| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.7M | +36.3% |
| R&D Expense | $18.8M | +122.8% |
| SG&A Expense | $9.2M | +40.6% |
| Operating Income | -$18.2M | -133.3% |
| Net Income | -$16.3M | -650.1% |
| EPS (Basic) | -$2.02 | -146.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.0M | +15.5% |
| Short-term Investments | $29.9M | — |
| Current Assets | $43.1M | +332.3% |
| Total Assets | $43.1M | +332.0% |
| Total Liabilities | $3.9M | +49.4% |
| Stockholders' Equity | $39.2M | +431.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.5M | -121.9% |
| Investing Cash Flow | -$28.7M | — |
| Financing Cash Flow | $46.4M | +316.2% |